Header Logo

Connection

Matthew Chersich to Nevirapine

This is a "connection" page, showing publications Matthew Chersich has written about Nevirapine.
Connection Strength

0,462
  1. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care. S Afr Med J. 2004 May; 94(5):362-6.
    View in: PubMed
    Score: 0,216
  2. A Safe Motherhood project in Kenya: assessment of antenatal attendance, service provision and implications for PMTCT. Trop Med Int Health. 2010 May; 15(5):584-91.
    View in: PubMed
    Score: 0,081
  3. Dandy-Walker variant in an infant prenatally exposed to antiretroviral medication. S Afr Med J. 2007 Oct; 97(10):947-8.
    View in: PubMed
    Score: 0,068
  4. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005 Aug 12; 19(12):1289-97.
    View in: PubMed
    Score: 0,059
  5. Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries. BMC Infect Dis. 2013 Nov 06; 13:522.
    View in: PubMed
    Score: 0,026
  6. Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet. 2002 Mar 23; 359(9311):992-3.
    View in: PubMed
    Score: 0,012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.